The Alliance for Safe Online Pharmacy in the EU

Tweet this page
<
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 16 Apr 2018
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

65,000€

Financial year: Dec 2016 - Nov 2017

Lobbyists (Full time equivalent)

0.5 Fte (1)

Lobbyists with EP accreditation

0

High-level Commission meetings

6

Lobbying Costs over the years

  • Info

    The Alliance for Safe Online Pharmacy in the EU Community Interest Company   (ASOP EU)

    EU Transparency Register

    273334013697-74 First registered on 27 May 2014

    Goals / Remit

    The Alliance for Safe Online Pharmacy in the EU (ASOP EU: www.asop.eu) is united by a single objective that by taking concerted voluntary actions, a safer environment for patients who choose to buy their medicines online can be created. ASOP EU comprises a growing number of members and observers including representatives from consumer, healthcare and patient groups, shippers, branded and generic pharmaceutical manufacturers, pharmacy stakeholders, wholesalers and traders, advertising networks, internet advertising and search companies, internet domain name registrars and registries, payment processors, law enforcement and regulatory bodies. Similar organisations also exist in the United States, in particular the Alliance for Safe Online Pharmacies (ASOP: http://buysaferx.pharmacy) and the Center for Safe Internet Pharmacies (CSIP: www.safemedsonline.org).

    ASOP EU seeks to be actively involved with all global actors and seeks to cooperate closely with Europol, Interpol, the European Commission (especially DG SANTE and DG GROWTH and DG Digital Single Market), the EU Observatory, national health regulators, law enforcement and customs authorities to help support the global effort to tackle this significant public health threat.

    ASOP EU strongly advocates the use of voluntary industry actions as these actions can help shape a safer marketplace and have the real potential to contribute to tackling illegal activity to complement the range of actions carried out by law enforcement and regulatory bodies.

    Main EU files targeted

    Campaigning to ensure that implementation of the Falsified Medicines Directive particularly the implementation of the Common Logo is successful. These will be achieved by raising public awareness through educational campaigns. And also by collaboration with appropriate government medical regulatory bodies. In addition through voluntary action the adoption of the Centre for Safe Internet Pharmacies Principles of Participation are adopted throughout Europe. Close liaison with its sister global organisation ASOP Global and also other not for profit organisations such Foundation Chirac, IRACM, Fight the Fakes, to effect the best collaboration to support each other's goals.

    Address

    Head Office
    London Road, 1386
    Leigh on Sea SS9 2UJ
    UNITED KINGDOM
  • People

    Total lobbyists declared

    1

    Employment timeLobbyists
    50%1

    Lobbyists (Full time equivalent)

    0.5

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    ASOP EU has a growing number of stakeholders; consumers, healthcare and patient groups, shippers, branded and generic pharmaceutical manufacturers, pharmacy bodies, wholesalers and traders, advertising networks, internet advertising and search companies, internet domain name registrars and registries, payment processors, law enforcement and regulatory bodies. The coalition implements a series of activities with its Members and Observers with a major focus on raising public awareness, catalysing voluntary sector actions and campaigning for improvements to policy and legislation. Members participate through teleconferencing and key face to face meetings in close liaison with its ASOP Global counterpart with whom it has a MOU. This is a vital area of activity to protect patients from the rising tide of falsified / counterfeit medicines across Europe and the world. We would urge you to join this important patient safety initiative.

    Person in charge of EU relations

    Mr Michael Isles (Director)

    Person with legal responsibility

    Mr Michael Isles (Director)

  • Categories

    Category

    III - Non-governmental organisations

    Subcategory

    Non-governmental organisations, platforms and networks and similar

  • Networking

    Affiliation

    None declared

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Dec 2016 - Nov 2017

    Lobbying costs for closed financial year

    65,000€

    Other financial info

    Each "Member" will be required to contribute 5000 euros if they are a commercial organisation. For non commercial organisations such as Trade Associations or Patient Groups or suchlike then no financial contribution will be required for these "Special Members". However such organisations may wish to support in kind by helping with the organisations administrative responsibilities or taking an active part in the organisations activities. "Observers" may also contribute their support in kind as per a "Member" or Special Member". The membership contributions will go to pay the costs of project work carried out by the Director Mike Isles. Other costs will be to maintain the website and pay for the accountancy work. In addition hosting of meetings and other projects to raise the level of awareness will be carried out.

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    None

    Communication activities

    The organisation is currently running educational campaigns via the use of Search engine "adwords" via a Google AdWord Grant which can help the patient and consumer find educational information that will help them to buy their medicines online (where it is legal to do so) more safely. In 2017 the plan is to extend this campaign to 5 Member Sates namely, France, Germany, Italy, Spain and UK). In addition it will continue to hold sharing best practice meetings with Member State regulatory meetings with those who are responsible for the implementation of the Falsified Medicines Directive and in particular the implementation of the Common Logo.

    Other activities

    “Falsified Medicines – the Cost to Public Health“
    ASOP EU round table discussion in the European Parliament highlights major public health problem.

    A report by the Alliance for Safe Online Pharmacy – EU (www.asop.eu) has highlighted the significant cost to the public health purse caused by highly organised criminal activity which results in patients and consumers buying falsified medicines online outside of Member State - controlled and regulated health systems. The report estimated that between 1-3bn euros is the cost of sales of falsified medicines in Europe in one year and that this number would increase despite all of the extra and successful measures being taken by law enforcement bodies such as INTERPOL and EUROPOL and national law enforcement bodies.
    ASOP - The Alliance for Safe Online Pharmacy – EU plays a crucial role in bringing together, on a voluntary and collaborative basis, all stakeholders to create an environment that enables patients to buy their medicines online safely (where it is legal to do so).


    ASOP EU brief the European Commission

    A meeting took place with the Head of Cabinet, Mrs Joanna Darmanin of the Health and Consumer Protection Directorate General (DG SANCO) http://ec.europa.eu/dgs/health_consumer/index_en.htmin Brussels on February 11th 2015. Also present from DG SANCO were Dr Rossella Delfino, Cabinet Member and Ms Maja Grzymkowski from the Health Systems and Products Division. The purpose of the meeting was to enable the ASOP EU delegation to brief the Commission on the very good progress that ASOP EU was achieving.

    In 2016, ASOP EU held a series of meetings to support the Falsified Medicines Directive and the Common Logo initiative; a key pan-European patient safety initiative

    The Falsified Medicines Directive's Common Logo promises to be a major step forward in the security of selling medicines at a distance and online. ASOP EU and its sister organisations, ASOP Global will be fully supporting this initiative. To mark the launch of this support and the publication of ASOP EU position paper, ASOP Global, ASOP EU and CSIP held a series of meetings with DG SANTE, Health Attaches of EU Member States and directly with Member State officials who are responsible for the implementation of the Common Logo. These discussions were aptly timed, as the Common Logo must be implemented by July 2015. A further follow up meeting was co-hosted by AIFA (The Italian Medicines Agency) 15th October 2015. The European Parliament (EP) own-initiative report on “Safer Healthcare in Europe: Improving Patient Safety and Fighting Antimicrobial Resistance” which was approved in the EU Parliament Plenary on 19 May 2015 incorporated a number of significant amendments in line with ASOP EU recommendations namely: 22. Calls on the Commission and the Member States to promote the introduction of the European logo provided for by Implementing Regulation (EU) No 699/2014 in order to identify clearly online pharmacies which offer medicines or sales to the public remotely while safeguarding consumers against the purchase of fake medicines, which are often a health hazard. During 2016 meetings were held in Brussels with Member State personnel involved with the successful implementation of the Common Logo. A teleconference with the same objective was held in January 2017 and a further meeting is planned for June 29th 2017 in the Google offices in Paris. For a fuller understanding of the activities of ASOP EU and the closely affiliated EAASM organisation (www.eaasm.eu) please go refer to the two latest newsletters which can be found here (http://www.eaasm.eu/cache/downloads/bpsu9lon87ww8c4kwcggg8ccg/ASOP%20EU%20and%20EAASM%20End%20Year%20Newsletter.pdf) and (http://www.eaasm.eu/cache/downloads/eqtrgxg8wdkock4g8wcc0cwck/EAASM%20-%20ASOP%20EU%20Mid-year%20Newsletter%202016.pdf)

  • Meetings

    Meetings

    6 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

Download this datacard